Generics makers appeal ruling on patents for Pozen's Treximet

09/8/2011 | MedCityNews.com

Alphapharm, Dr. Reddy's Laboratories and Par Pharmaceutical appealed a court decision that upholds patents covering Pozen's migraine drug Treximet. The ruling blocks FDA approval of the firms' generic versions before patent expiration.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC